Authors:
Baykova, VN
Durnov, LA
Chernova, NV
Zaeva, GE
Zaitseva, LA
Dumbrais, KO
Zakharova, NV
Gracheva, IV
Leonidova, YA
Lebedev, VI
Moiseenko, EI
Citation: Vn. Baykova et al., Tyrosine metabolism, antioxidant status and some parameters of free-radical lipid peroxidation in children suffering from melanoma and pigmented nevi, EXP ONCOL, 22(3), 2000, pp. 142-147
Citation: Oncology 2000 - Abstracts from the 2nd Congress of Oncologists from countries of the Commonwealth of Independent States (Kiev, May 23-26, 2000) - An addition to those published in the supplement to the journal "Experimental Oncology" (2000, vol 22, Suppl.), EXP ONCOL, 22(3), 2000, pp. 165-168
Citation: Zm. Bhujwalla et al., Insights into tumor vascularization using magnetic resonance imaging and spectroscopy, EXP ONCOL, 22(1-2), 2000, pp. 3-7
Citation: P. Vaupel et al., Microtopology of local perfusion, oxygenation, metabolic and energetic status, and interstitial pH in malignant tumors: Techniques and characterization, EXP ONCOL, 22(1-2), 2000, pp. 15-25
Authors:
Butenko, ZA
Zavelevich, MP
Smirnova, IA
Khaetsky, IK
Phylchenkov, AA
Kishinskaya, EG
Baranovskaya, LN
Citation: Za. Butenko et al., Different etoposide-induced apoptotic response of human malignant lymphoidcell lines, EXP ONCOL, 22(1-2), 2000, pp. 26-31
Authors:
Blitvich, BJ
Ward, BK
Frost, FA
Ingram, DM
Byme, MJ
Ratajczak, T
Citation: Bj. Blitvich et al., Use of fine-needle aspirates for the identification of mutations within the estrogen receptor-alpha hormone-binding domain in tamoxifen-resistant human breast carcinomas, EXP ONCOL, 22(1-2), 2000, pp. 38-43
Citation: Ep. Smorodin et al., The application of human natural polyclonal IgG-antibodies to Thomsen-Friedenreich epitope (TFE) for evaluation of TFE expression in cancer-associated mucins, EXP ONCOL, 22(1-2), 2000, pp. 44-47
Authors:
Blasiak, J
Smolarz, B
Kubryn, I
Kulig, A
Dziki, A
Ulanska, J
Pander, B
Citation: J. Blasiak et al., Plasminogen activator inhibitor-1 (PAI-1) level and 4G/5G genetic polymorphism in patients with colorectal cancer, EXP ONCOL, 22(1-2), 2000, pp. 48-51
Citation: Y. Tanaka et Y. Harima, Oncoprotein expression predicts response to radiotherapy or thermoradiotherapy in human cervical cancer, EXP ONCOL, 22(1-2), 2000, pp. 52-58
Authors:
Glehen, O
Peyrat, P
Beaujard, A
Caillot, JL
Francois, Y
Gueugniaud, PY
Garbit, F
Bienvenu, J
Vignal, J
Gilly, FN
Citation: O. Glehen et al., Abdominal cancer with peritoneal carcinomatosis treated by peritonectomy procedure and intraperitoneal chemohyperthermia, EXP ONCOL, 22(1-2), 2000, pp. 59-63
Citation: N. Imamura, Hematological disorders induced by irradiation in Hiroshima and Chernobyl:Analysis of myeloperoxidase-negative acute leukemias by flow cytometry andpoint mutations of p53 suppressor oncogene in myelodysplastic syndrome, EXP ONCOL, 22(1-2), 2000, pp. 64-72
Citation: N. Oguma et al., Various response patterns of Ph ' cells to IFN-alpha in patients with chronic myelocytic leukemia, EXP ONCOL, 22(1-2), 2000, pp. 73-77
Authors:
Hiyama, T
Haruma, K
Kitadai, Y
Tanaka, S
Yoshihara, M
Sumii, K
Shimamoto, F
Kajiyama, G
Citation: T. Hiyama et al., Eradication therapy of Helicobacter pylori for low-grade mucosa-associatedlymphoid tissue lymphomas of the stomach, EXP ONCOL, 22(1-2), 2000, pp. 78-81
Citation: N. Imamura, High incidence of neutropenia caused by NK or NK like T-cell proliferativedisorders among atomic bomb survivors, EXP ONCOL, 22(1-2), 2000, pp. 82-83
Citation: N. Imamura, Annotation. New treatment strategy for malignant hematologic disorders andneoplasia by graft versus leukemia/tumor reaction, EXP ONCOL, 22(1-2), 2000, pp. 86-87
Authors:
Saito, T
Seo, S
Tanosaki, R
Takaue, Y
Mineishi, S
Citation: T. Saito et al., Non-myeloablative stem cell transplant using 2-chlorodeoxyadenosine (2-CdA) in a patient with myelodysplastic syndrome (MDS), EXP ONCOL, 22(1-2), 2000, pp. 88-90
Authors:
Lukyanova, NY
Kulik, GI
Yurchenko, OV
Shatrova, KM
Vorobyova, LI
Svintitsky, VS
Evtushenko, GV
Chekhun, VF
Citation: Ny. Lukyanova et al., Expression of p53 and Bcl-2 proteins in epithelial ovarian carcinoma with different grade of differentiation, EXP ONCOL, 22(1-2), 2000, pp. 91-93